Beam Therapeutics (BEAM) Interest & Investment Income (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Interest & Investment Income data on file, last reported at $9.9 million in Q1 2026.

• On a quarterly basis, Interest & Investment Income changed 0.03% year-over-year to $9.9 million in Q1 2026; TTM through Mar 2026 was $43.7 million, a 7.16% decrease from a year earlier, with the FY2025 full-year figure at $43.7 million, down 10.92% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $9.9 million, down from $10.6 million in the prior quarter.
• Over the last five years, Interest & Investment Income for BEAM reached as high as $14.2 million in Q2 2024 and fell as low as $644000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $9.7 million across 5 years, with a median of $10.9 million in 2025.
• Across the five-year window, Interest & Investment Income jumped 55255.56% in 2022 and dropped 16.75% in 2025, its largest moves.
• Year by year, Interest & Investment Income stood at $7.6 million in 2022, then jumped by 58.51% to $12.1 million in 2023, then decreased by 9.42% to $10.9 million in 2024, then decreased by 2.64% to $10.6 million in 2025, then fell by 7.27% to $9.9 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $9.9 million in Q1 2026, $10.6 million in Q4 2025, and $10.9 million in Q3 2025.